Drug intelligence / Profile preview

3-phenyl-5-(1H-pyrazol-3-yl)isoxazole

Development stage: Unknown
Modality: Small Molecules

Overview

**Description:** 3‑phenyl‑5‑(1H‑pyrazol‑3‑yl)isoxazole is a synthetic small molecule belonging to the isoxazoles and pyrazoles class of organic compounds. It features a phenyl group and a pyrazolyl group attached to an isoxazole ring, giving it unique chemical properties. The compound has been investigated as a lead structure in medicinal chemistry for the development of new pharmaceuticals targeting diseases such as cancer or inflammation, but its mechanism of action remains unclear and no specific biological target has been established. It is considered experimental with no approved medical indications or clinical trial activity reported[1][2][3].

Other names: 264225-67-43-PHENYL-5-(1H-PYRAZOL-3-YL)ISOXAZOLE3-(3-phenyisoxazol–5–yl)-1H-pyrazolePyrazolylisoxazole, 14

Targets

RORγt

Beyond the preview

Go deeper on 3-phenyl-5-(1H-pyrazol-3-yl)isoxazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-phenyl-5-(1H-pyrazol-3-yl)isoxazole.

Explore the full profile